Literature DB >> 10909888

Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage?

Y Murao1, D B Hoyt, W Loomis, S Namiki, N Patel, P Wolf, W G Junger.   

Abstract

Hypertonic saline (HS) resuscitation has been reported to prevent lung damage by suppressing neutrophil activation in animal models. Data on the effectiveness of HS to prevent organ damage in the clinical setting are inconsistent. We investigated whether the timing of HS administration relative to neutrophil activation could affect its potential to block neutrophil responses. Different likely clinical circumstances were simulated in vitro by exposing human neutrophils to HS at different time points before and after activation with N-formyl-methionyl-leucyl-phenylalanine (fMLP). The in vivo effect of using HS as a secondary resuscitation fluid was determined with a mouse model of hemorrhage. BALB/c mice were hemorrhaged (40 +/- 5 mmHg) for 1 h and partially resuscitated with HS or Lactated Ringer's (LR) 20 min before completing resuscitation with LR or HS, respectively. Neutrophil activation parameters were determined 2 h after complete resuscitation and lung damage was assessed after 24 h. The length of exposure to physiologically relevant HS levels (20 mM) determined the suppressive effect on in vitro neutrophil superoxide formation. HS treatment caused a transient state of suppression during which neutrophil activation was suppressed; however, HS was unable to suppress cells that were stimulated with fMLP before HS was added. Accordingly, in vivo lung damage was greater in animals that received HS after they had been partially resuscitated with LR compared to mice that received HS before LR (P < 0.05). We conclude that timing of exposure to HS affects neutrophil responses in vitro and may reduce the potential of HS resuscitation to prevent lung injury in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909888     DOI: 10.1097/00024382-200014010-00004

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Resuscitation of traumatic hemorrhagic shock patients with hypertonic saline-without dextran-inhibits neutrophil and endothelial cell activation.

Authors:  Wolfgang G Junger; Shawn G Rhind; Sandro B Rizoli; Joseph Cuschieri; Maria Y Shiu; Andrew J Baker; Linglin Li; Pang N Shek; David B Hoyt; Eileen M Bulger
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

2.  Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases.

Authors:  Yu Chen; Yi Bao; Jingping Zhang; Tobias Woehrle; Yuka Sumi; Stephan Ledderose; Xiaoou Li; Carola Ledderose; Wolfgang G Junger
Journal:  Shock       Date:  2015-09       Impact factor: 3.454

3.  A3 adenosine receptor inhibition improves the efficacy of hypertonic saline resuscitation.

Authors:  Yoshiaki Inoue; Hiroshi Tanaka; Yuka Sumi; Tobias Woehrle; Yu Chen; Mark I Hirsh; Wolfgang G Junger
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

Review 4.  Salt of the earth or a drop in the ocean? A pathophysiological approach to fluid resuscitation.

Authors:  P Gosling
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

5.  Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis.

Authors:  Yoshiaki Inoue; Yu Chen; Reinhard Pauzenberger; Mark I Hirsh; Wolfgang G Junger
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

6.  Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation.

Authors:  Conor J Shields; Adrian W O'Sullivan; Jiang H Wang; Desmond C Winter; William O Kirwan; H Paul Redmond
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

Review 7.  Therapeutic applications.

Authors:  Stephen Tilley; Jon Volmer; Maryse Picher
Journal:  Subcell Biochem       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.